Overview
Jennifer A. Minessale, APNP, is a board-certified, experienced nurse practitioner specializing in oncology at Ascension Wisconsin in Milwaukee, Mount Pleasant, Wauwatosa, and Franklin, WI. She listens to understand you and your health concerns, taking the time to get to know you and your family's health history and create a personalized care plan that's right for you. As a NP, Jennifer can diagnose illness and injury, prescribe medication and provide non-surgical care.
Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer.
Dr. Minessale is board certified in American Nurses Credentialing Center - Adult Nurse Practitioner - Certified (ANP-BC). Dr. Minessale is currently accepting new patients.
Graduate Institution
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- PPO
- EPO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2301 N Lake Dr, Milwaukee, WI 53211
5000 W Chambers St, Milwaukee, WI 53210
2350 N Lake Dr, Ste 201, Milwaukee, WI 53211
201 N Mayfair Rd, Fl 3, Wauwatosa, WI 53226
201 N Mayfair Rd, Wauwatosa, WI 53226
10101 S 27th St, Franklin, WI 53132
3809 Spring St, Mount Pleasant, WI 53405
Clinical Cancer Center - Froedtert Hospital
John Charlson is an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Charlson is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Synovial Sarcoma, and Undifferentiated Pleomorphic Sarcoma. Dr. Charlson is board certified in Medical Oncology. Dr. Charlson is currently accepting new patients.
Clinical Cancer Center - Froedtert Hospital
Dr. Kurzrock is a world-renowned leader in precision oncology and rare cancers research. She is the Associate Director of Clinical Research for the Medical College of Wisconsin Cancer Center, Associate Director of Precision Oncology at the Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine and the founding director of the Michels Rare Cancers Research Laboratories at the MCW Cancer Center. She is recognized as one of the world’s 25 most important voices in precision medicine and one of the most highly cited scientists globally. She has authored over 950 scientific and medical publications. Dr. Kurzrock is the Chair for the Early Therapeutics and Rare Cancers Committee (SWOG NCI) — one of the largest clinical trials cooperative groups in the country — and has been the principal investigator for more than 100 early-phase clinical trials, leading eight life-changing drugs to FDA approval. In 2022, Dr. Kurzrock and the DART rare cancer study team received the National Cancer Institute Director’s Award of Merit for outstanding work. Dr. Kurzrock is highly rated in 37 conditions, according to our data. Her clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Castleman Disease, Multicentric Castleman Disease (MCD), Lymphoid Hyperplasia, and Tissue Biopsy. Dr. Kurzrock is board certified in Internal Medicine and Medical Oncology. Dr. Kurzrock is currently accepting new patients.
Froedtert And The Medical College Of Wisconsin Froedtert Hospital
Parameswaran Hari is an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Hari is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Primary Amyloidosis, Bone Marrow Transplant, and Splenectomy.
Frequently Asked Questions about Dr. Jennifer A. Minessale
How do I make an appointment with Dr. Jennifer A. Minessale?
You can book an appointment with Dr. Jennifer A. Minessale by calling their office at 414-291-1000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jennifer A. Minessale a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jennifer A. Minessale is classified as an Experienced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jennifer A. Minessale specialize in?
While Dr. Jennifer A. Minessale is a Oncology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Jennifer A. Minessale accept my insurance?
Dr. Jennifer A. Minessale accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 414-291-1000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Minessale isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.